Mersana Therapeutics Inc

NASDAQ:MRSN 1:00:00 PM EDT

0.29

+0.01 (+3.50%)

4:59:58 PM EDT: $0.30 +0.01 (+2.18%)

Market Cap (Intraday)	36.08M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$6.36 Million
Adjusted EPS	-$0.16

See more estimates

10-Day MA	$0.31
50-Day MA	$0.36
200-Day MA	$1.06

See more pivots

Mersana Therapeutics Inc Stock, NASDAQ:MRSN

840 Memorial Drive, Cambridge, Massachusetts 02139

United States of America

Phone: +1.617.498.0020

Number of Employees: 102

http://www.mersana.com

Description

Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592. The company was founded by Mikhail Papisov in 2001 and is headquartered in Cambridge, MA.